| 1 |
กัลยาณี สวรรยาวิสุทธิ์ |
2022 |
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma |
Asian Pacific Journal of Cancer Prevention |
| 2 |
กุลธิดา เวทีวุฒาจารย์ |
2022 |
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma |
Asian Pacific Journal of Cancer Prevention |
| 3 |
ชฎามาศ สกลศิลป์ศิริ |
2022 |
Simulation Studies on Signature Interactions between Cancer DNA and Cysteamine-Decorated AuNPs for Universal Cancer Screening |
ACS Applied Nano Materials |
| 4 |
พัชรี บุญศิริ |
2022 |
Anti-Proteus Activity, Anti-Struvite Crystal, and Phytochemical Analysis of Sida acuta Burm. F. Ethanolic Leaf Extract |
Molecules |
| 5 |
รศนา วงศ์รัตนชีวิน |
2022 |
Co-evolutionary Signals Identify Burkholderia pseudomallei Survival Strategies in a Hostile Environment |
Molecular Biology and Evolution |
| 6 |
เรณู ทานันท์ |
2022 |
Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand |
PLoS ONE |
| 7 |
โสพิศ วงศ์คำ |
2022 |
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma |
Asian Pacific Journal of Cancer Prevention |
| 8 |
อาทิตย์ ศิลป์ศิริวานิชย์ |
2022 |
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways |
Life |
| 9 |
อุบล ชาอ่อน |
2022 |
Effects of Boric Acid and Storage Temperature on the Analysis of Microalbumin Using Aptasensor-Based Fluorescent Detection |
Biosensors |
| 10 |
สุกัญญา เลือง |
2022 |
Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment |
Experimental Cell Research |
| 11 |
ภาณุพงศ์ มหาลาภบุตร |
2022 |
1′-Acetoxychavicol Acetate from Alpinia galanga Represses Proliferation and Invasion, and Induces Apoptosis via HER2-signaling in Endocrine-Resistant Breast Cancer Cells |
Planta Medica |
| 12 |
จารุพงษ์ แสงบุญมี |
2022 |
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract |
In Vivo |